According to Stryker Corporation's latest financial reports the company's current EPS (TTM) is $6.50. In 2021 the company made an earnings per share (EPS) of $5.29 an increase over its 2020 EPS that were of $4.27.
Year | EPS | Change |
---|---|---|
2022 (TTM) | $6.50 | 22.87% |
2021 | $5.29 | 23.89% |
2020 | $4.27 | -23.34% |
2019 | $5.57 | -41.31% |
2018 | $9.49 | 247.62% |
2017 | $2.73 | -38.1% |
2016 | $4.41 | 15.45% |
2015 | $3.82 | 140.25% |
2014 | $1.59 | -40% |
2013 | $2.65 | -22.29% |
2012 | $3.41 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() Medtronic MDT | $3.23 | -50.31% | ๐ฎ๐ช Ireland |
![]() Baxter BAX | -$4.71 | -172.46% | ๐บ๐ธ USA |
![]() Boston Scientific BSX | $0.42 | -93.54% | ๐บ๐ธ USA |
![]() Edwards Lifesciences EW | $2.34 | -64.00% | ๐บ๐ธ USA |
![]() Waters Corporation WAT | $11.54 | 77.54% | ๐บ๐ธ USA |
![]() Integra LifeSciences IART | $2.07 | -68.22% | ๐บ๐ธ USA |
![]() Smith & Nephew
SNN | $1.12 | -82.74% | ๐ฌ๐ง UK |
![]() Owens & Minor
OMI | $1.65 | -74.62% | ๐บ๐ธ USA |